First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
Blood · 2024
DOI: 10.1182/blood.2023021349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, 2024. Verfasst von Ilaria Crespiatico und 39 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases, Hematopoietic System. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
SETBP1 mutations are found in various clonal myeloid disorders. However, it is unclear whether they can initiate leukemia, because SETBP1 mutations typically appear as later events during oncogenesis. To answer this question, we generated a mouse model expressing mutated SETBP1 in hematopoietic tissue: this model showed profound alterations in the differentiation program of hematopoietic progenitors and developed a myeloid neoplasm with megakaryocytic dysplasia, splenomegaly, and bone marrow fibrosis, prompting us to investigate SETBP1 mutations in a cohort of 36 triple-negative primary myelofibrosis (TN-PMF) cases. We identified 2 distinct subgroups, one carrying SETBP1 mutations and the other completely devoid of somatic variants. Clinically, a striking difference in disease aggressiveness was noted, with patients with SETBP1 mutation showing a much worse clinical course. In contrast to myelodysplastic/myeloproliferative neoplasms, in which SETBP1 mutations are mostly found as a late clonal event, single-cell clonal hierarchy reconstruction in 3 patients with TN-PMF from our cohort revealed SETBP1 to be a very early event, suggesting that the phenotype of the different SETBP1+ disorders may be shaped by the opposite hierarchy of the same clonal SETBP1 variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy.
- Neuroepigenetics Unit, Division of Neuroscience, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Scientific Institute, Milan, Italy.
- Hematology Division and Bone Marrow Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico San Gerardo dei Tintori, Monza, Italy.
- Department of Pathology, University of Milan-Bicocca, Monza, Italy.
- Biomedical Research in Melanoma-Animal Models and Cancer Laboratory, Vall d'Hebron Research Institute, Vall d'Hebron Hospital Barcelona UAB, Barcelona, Spain.
- Department of Pathology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy.
ORCID-Profile: Ilaria Crespiatico, Mattia Zaghi, Cristina Mastini, Deborah D'Aliberti, Mario Mauri, Carl Mirko Mercado, Diletta Fontana, Silvia Spinelli, Valentina Crippa, Elena Inzoli, Beatrice Manghisi, Ivan Civettini, Daniele Ramazzotti, Michele Gengotti, Cristiana Barone, Mara Riminucci, Alessandro Corsi, Massimo Breccia, Alessandro Morotti, Daniela Cilloni, Aldo Roccaro, Antonio Sacco, Emanuele Azzoni, Alessandro Sessa, Carlo Gambacorti-Passerini, Luca Mologni, Rocco Piazza
Zitieren
APA
Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C. M., Fontana, D., Spinelli, S., Crippa, V., Inzoli, E., Manghisi, B., Civettini, I., Ramazzotti, D., Sangiorgio, V., Gengotti, M., Brambilla, V., Aroldi, A., Banfi, F., Barone, C., …, & Piazza, R. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood. https://doi.org/10.1182/blood.2023021349
Vancouver
Crespiatico I, Zaghi M, Mastini C, D'Aliberti D, Mauri M, Mercado CM, et al. First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. Blood. 2024. doi:10.1182/blood.2023021349
BibTeX
@article{Crespiatico2024,
author = {Crespiatico, Ilaria and Zaghi, Mattia and Mastini, Cristina and D'Aliberti, Deborah and Mauri, Mario and Mercado, Carl Mirko and Fontana, Diletta and Spinelli, Silvia and Crippa, Valentina and Inzoli, Elena and Manghisi, Beatrice and Civettini, Ivan and Ramazzotti, Daniele and Sangiorgio, Valentina and Gengotti, Michele and Brambilla, Virginia and Aroldi, Andrea and Banfi, Federica and Barone, Cristiana and Orsenigo, Roberto and Riera, Ludovica and Riminucci, Mara and Corsi, Alessandro and Breccia, Massimo and Morotti, Alessandro and Cilloni, Daniela and Roccaro, Aldo and Sacco, Antonio and Stagno, Fabio and Serafini, Marta and Mottadelli, Federica and Cazzaniga, Giovanni and Pagni, Fabio and Chiarle, Roberto and Azzoni, Emanuele and Sessa, Alessandro and Gambacorti-Passerini, Carlo and Elli, Elena Maria and Mologni, Luca and Piazza, Rocco},
title = {First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis},
journal = {Blood},
year = {2024},
doi = {10.1182/blood.2023021349}
}
EUVIMED